Innoviva (INVA) News Today $18.08 +0.01 (+0.06%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$18.08 0.00 (-0.03%) As of 02/21/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period StockNews.com Downgrades Innoviva (NASDAQ:INVA) to HoldStockNews.com lowered Innoviva from a "buy" rating to a "hold" rating in a research report on Saturday.February 22 at 2:21 AM | marketbeat.comHussman Strategic Advisors Inc. Buys 42,000 Shares of Innoviva, Inc. (NASDAQ:INVA)Hussman Strategic Advisors Inc. grew its stake in Innoviva, Inc. (NASDAQ:INVA - Free Report) by 33.3% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 168,000 shares of the biotechnology company's stockFebruary 21 at 6:37 AM | marketbeat.comInnoviva, Inc. (NASDAQ:INVA) Short Interest UpdateInnoviva, Inc. (NASDAQ:INVA - Get Free Report) was the target of a significant drop in short interest in the month of January. As of January 31st, there was short interest totalling 8,810,000 shares, a drop of 10.2% from the January 15th total of 9,810,000 shares. Based on an average daily volume of 680,800 shares, the days-to-cover ratio is currently 12.9 days. Approximately 14.2% of the company's stock are short sold.February 18, 2025 | marketbeat.comNewtyn Management, LLC Increases Stake in Theravance Biopharma IncFebruary 14, 2025 | gurufocus.comEntropy Technologies LP Acquires New Holdings in Innoviva, Inc. (NASDAQ:INVA)Entropy Technologies LP bought a new position in shares of Innoviva, Inc. (NASDAQ:INVA - Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm bought 14,298 shares of the biotechnology company's stock, valued at approximately $248,000. Other institutionFebruary 14, 2025 | marketbeat.comInnoviva (NASDAQ:INVA) Lowered to Hold Rating by StockNews.comStockNews.com cut shares of Innoviva from a "buy" rating to a "hold" rating in a research note on Thursday.February 13, 2025 | marketbeat.comInnoviva to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences ConferenceFebruary 6, 2025 | finance.yahoo.comInnoviva (NASDAQ:INVA) Upgraded at StockNews.comStockNews.com upgraded Innoviva from a "hold" rating to a "buy" rating in a research report on Wednesday.February 6, 2025 | marketbeat.comPacer Advisors Inc. Has $50.87 Million Stake in Innoviva, Inc. (NASDAQ:INVA)Pacer Advisors Inc. grew its holdings in Innoviva, Inc. (NASDAQ:INVA - Free Report) by 4.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 2,932,113 shares of the biotechnology company's stock after buJanuary 28, 2025 | marketbeat.comCantor Fitzgerald Weighs in on Innoviva FY2025 EarningsInnoviva, Inc. (NASDAQ:INVA - Free Report) - Investment analysts at Cantor Fitzgerald issued their FY2025 earnings per share (EPS) estimates for Innoviva in a note issued to investors on Tuesday, January 21st. Cantor Fitzgerald analyst L. Chen expects that the biotechnology company will post earnJanuary 22, 2025 | marketbeat.comJPMorgan Chase & Co. Has $11.17 Million Stake in Innoviva, Inc. (NASDAQ:INVA)JPMorgan Chase & Co. boosted its stake in Innoviva, Inc. (NASDAQ:INVA - Free Report) by 14.2% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 578,243 shares of the biotechnology company's sJanuary 13, 2025 | marketbeat.comInnoviva (NASDAQ:INVA) Downgraded to Hold Rating by StockNews.comStockNews.com lowered shares of Innoviva from a "buy" rating to a "hold" rating in a report on Tuesday.December 31, 2024 | marketbeat.comBarclays PLC Purchases 72,192 Shares of Innoviva, Inc. (NASDAQ:INVA)Barclays PLC boosted its holdings in shares of Innoviva, Inc. (NASDAQ:INVA - Free Report) by 254.2% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 100,594 shares of the biotechnology compaDecember 27, 2024 | marketbeat.comInnoviva's (NASDAQ:INVA) investors will be pleased with their 26% return over the last five yearsDecember 25, 2024 | finance.yahoo.comInnoviva, Inc. (NASDAQ:INVA) Shares Bought by Jane Street Group LLCJane Street Group LLC boosted its holdings in shares of Innoviva, Inc. (NASDAQ:INVA - Free Report) by 46.4% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 136,361 shares of the biotechnology company's stoDecember 22, 2024 | marketbeat.comWellington Management Group LLP Lowers Holdings in Innoviva, Inc. (NASDAQ:INVA)Wellington Management Group LLP reduced its stake in shares of Innoviva, Inc. (NASDAQ:INVA - Free Report) by 60.3% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 28,166 shares of the biotechnology compDecember 21, 2024 | marketbeat.comInnoviva, Inc. (NASDAQ:INVA) Short Interest Down 7.5% in NovemberInnoviva, Inc. (NASDAQ:INVA - Get Free Report) was the recipient of a significant decrease in short interest in the month of November. As of November 30th, there was short interest totalling 10,730,000 shares, a decrease of 7.5% from the November 15th total of 11,600,000 shares. Currently, 17.3% of the company's shares are sold short. Based on an average daily volume of 601,600 shares, the days-to-cover ratio is presently 17.8 days.December 16, 2024 | marketbeat.comInnoviva In Deal With Basilea Pharma To Buy U.S. Marketing Rights For ZevteraDecember 16, 2024 | markets.businessinsider.comInnoviva Specialty Therapeutics Signs Exclusive Distribution and Licensing Agreement to Acquire U.S. Marketing Rights for Zevtera® (ceftobiprole)December 16, 2024 | finance.yahoo.comBasilea Collaborates With Innoviva Specialty Therapeutics For Commercialization Of Zevtera In The USDecember 16, 2024 | markets.businessinsider.comBasilea announces agreement with Innoviva Specialty Therapeutics for the commercialization of antibiotic Zevtera® (ceftobiprole) in the United StatesDecember 16, 2024 | globenewswire.comCharles Schwab Investment Management Inc. Reduces Stock Position in Innoviva, Inc. (NASDAQ:INVA)Charles Schwab Investment Management Inc. decreased its holdings in Innoviva, Inc. (NASDAQ:INVA - Free Report) by 11.9% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 732,296 shares of the biotechnology companDecember 9, 2024 | marketbeat.comSystematic Financial Management LP Raises Holdings in Innoviva, Inc. (NASDAQ:INVA)Systematic Financial Management LP grew its holdings in Innoviva, Inc. (NASDAQ:INVA - Free Report) by 4.7% in the 3rd quarter, according to the company in its most recent filing with the SEC. The firm owned 1,979,073 shares of the biotechnology company's stock after buying an additional 89,633 sharDecember 5, 2024 | marketbeat.comRedwood Investment Management LLC Reduces Stock Position in Innoviva, Inc. (NASDAQ:INVA)Redwood Investment Management LLC lowered its stake in shares of Innoviva, Inc. (NASDAQ:INVA - Free Report) by 22.9% during the third quarter, according to its most recent Form 13F filing with the SEC. The fund owned 140,912 shares of the biotechnology company's stock after selling 41,852 shares duDecember 5, 2024 | marketbeat.comInnoviva to Participate in the Citi 2024 Global Healthcare ConferenceNovember 26, 2024 | businesswire.comWestfield Capital Management Co. LP Lowers Holdings in Innoviva, Inc. (NASDAQ:INVA)Westfield Capital Management Co. LP reduced its position in shares of Innoviva, Inc. (NASDAQ:INVA - Free Report) by 25.6% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,994,589 shares of the biotecNovember 25, 2024 | marketbeat.comSegall Bryant & Hamill LLC Acquires New Shares in Innoviva, Inc. (NASDAQ:INVA)Segall Bryant & Hamill LLC acquired a new stake in Innoviva, Inc. (NASDAQ:INVA - Free Report) in the third quarter, according to its most recent filing with the SEC. The fund acquired 37,039 shares of the biotechnology company's stock, valued at approximately $715,000. Segall Bryant & Hamill LLC owNovember 25, 2024 | marketbeat.comInnoviva, Inc. (NASDAQ:INVA) Shares Sold by Jennison Associates LLCJennison Associates LLC decreased its stake in Innoviva, Inc. (NASDAQ:INVA - Free Report) by 36.0% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 66,056 shares of the biotechnology company's stock after selling 37,171 shares dNovember 24, 2024 | marketbeat.comPacer Advisors Inc. Sells 547,610 Shares of Innoviva, Inc. (NASDAQ:INVA)Pacer Advisors Inc. lessened its stake in shares of Innoviva, Inc. (NASDAQ:INVA - Free Report) by 16.3% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,810,951 shares of the biotechnology company's stock after selling 5November 22, 2024 | marketbeat.comEmpowered Funds LLC Sells 173,122 Shares of Innoviva, Inc. (NASDAQ:INVA)Empowered Funds LLC lowered its stake in Innoviva, Inc. (NASDAQ:INVA - Free Report) by 64.3% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 95,964 shares of the biotechnology company's stock after selling 173,122 sharesNovember 21, 2024 | marketbeat.comInnoviva Reports Strong Q3 Growth Amidst Strategic AdvancesNovember 20, 2024 | markets.businessinsider.comInnoviva IncNovember 16, 2024 | money.usnews.comMadison Avenue Partners, LP Expands Stake in Theravance Biopharma IncNovember 14, 2024 | gurufocus.comInnoviva (NASDAQ:INVA) Hits New 52-Week High - Here's What HappenedInnoviva (NASDAQ:INVA) Reaches New 12-Month High - What's Next?November 12, 2024 | marketbeat.com29,710 Shares in Innoviva, Inc. (NASDAQ:INVA) Purchased by CWA Asset Management Group LLCCWA Asset Management Group LLC bought a new stake in Innoviva, Inc. (NASDAQ:INVA - Free Report) during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 29,710 shares of the biotechnology company's stock, valued atNovember 12, 2024 | marketbeat.comInnoviva reports Q3 EPS 2c, two estimates 26cNovember 8, 2024 | markets.businessinsider.comInnoviva Reports Third Quarter 2024 Financial Results; Highlights Recent Company ProgressNovember 6, 2024 | businesswire.comVanguard Group Inc's Strategic Acquisition in Theravance Biopharma IncNovember 5, 2024 | gurufocus.comHarbor Capital Advisors Inc. Grows Holdings in Innoviva, Inc. (NASDAQ:INVA)Harbor Capital Advisors Inc. grew its position in shares of Innoviva, Inc. (NASDAQ:INVA - Free Report) by 44.1% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 136,722 shares of the biNovember 5, 2024 | marketbeat.comInnoviva (NASDAQ:INVA) Stock, Option ChainOctober 31, 2024 | benzinga.comAssenagon Asset Management S.A. Sells 365,986 Shares of Innoviva, Inc. (NASDAQ:INVA)Assenagon Asset Management S.A. lowered its holdings in Innoviva, Inc. (NASDAQ:INVA - Free Report) by 45.2% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 444,222 shares of the biotechnology companyOctober 29, 2024 | marketbeat.comInnoviva, Inc. (NASDAQ:INVA) Shares Sold by SG Americas Securities LLCSG Americas Securities LLC lowered its holdings in shares of Innoviva, Inc. (NASDAQ:INVA - Free Report) by 84.3% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 12,759 shares of the biotechnology company'sOctober 22, 2024 | marketbeat.comInnoviva (NASDAQ:INVA) Sets New 12-Month High - Here's WhyInnoviva (NASDAQ:INVA) Hits New 1-Year High - Should You Buy?October 16, 2024 | marketbeat.comInnoviva, Inc. (NASDAQ:INVA) Stock Position Decreased by Exchange Traded Concepts LLCExchange Traded Concepts LLC lowered its holdings in Innoviva, Inc. (NASDAQ:INVA - Free Report) by 15.2% during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 154,785 shares of the biotechnology company's stock after selOctober 15, 2024 | marketbeat.comSquarepoint Ops LLC Acquires New Holdings in Innoviva, Inc. (NASDAQ:INVA)Squarepoint Ops LLC bought a new position in Innoviva, Inc. (NASDAQ:INVA - Free Report) in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 134,019 shares of the biotechnology company's stock, valued at approximately $2,198,0October 4, 2024 | marketbeat.comMarshall Wace LLP Boosts Stock Position in Innoviva, Inc. (NASDAQ:INVA)Marshall Wace LLP grew its position in Innoviva, Inc. (NASDAQ:INVA - Free Report) by 823.3% during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 204,752 shares of the biotechnology company's stock after purchasing an additional 182,575 shares during tOctober 3, 2024 | marketbeat.comInnoviva, Inc.'s (NASDAQ:INVA) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?September 30, 2024 | finance.yahoo.comSystematic Financial Management LP Has $30.99 Million Holdings in Innoviva, Inc. (NASDAQ:INVA)Systematic Financial Management LP reduced its position in shares of Innoviva, Inc. (NASDAQ:INVA - Free Report) by 8.9% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,889,440 shares of the biotechSeptember 29, 2024 | marketbeat.comDimensional Fund Advisors LP Increases Stake in Innoviva, Inc. (NASDAQ:INVA)Dimensional Fund Advisors LP increased its position in shares of Innoviva, Inc. (NASDAQ:INVA - Free Report) by 1.5% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 4,684,594 shares of the biotechnology companSeptember 27, 2024 | marketbeat.comCaxton Associates LP Acquires 72,716 Shares of Innoviva, Inc. (NASDAQ:INVA)Caxton Associates LP boosted its position in Innoviva, Inc. (NASDAQ:INVA - Free Report) by 204.5% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 108,277 shares of the biotechnology company's stock after puSeptember 26, 2024 | marketbeat.com Get Innoviva News Delivered to You Automatically Sign up to receive the latest news and ratings for INVA and its competitors with MarketBeat's FREE daily newsletter. Email Address INVA Media Mentions By Week INVA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. INVA News Sentiment▼1.050.60▲Average Medical News Sentiment INVA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. INVA Articles This Week▼32▲INVA Articles Average Week Get Innoviva News Delivered to You Automatically Sign up to receive the latest news and ratings for INVA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Amicus Therapeutics News Ligand Pharmaceuticals News BioCryst Pharmaceuticals News Dynavax Technologies News Geron News Celldex Therapeutics News MannKind News Myriad Genetics News Novavax News OPKO Health News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:INVA) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | Sponsored[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Innoviva, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Innoviva With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
